2011
DOI: 10.1016/j.ijom.2011.01.008
|View full text |Cite
|
Sign up to set email alerts
|

In vivo production of mineralised tissue pieces for clinical use: a qualitative pilot study using human dental pulp cell

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
18
0

Year Published

2012
2012
2023
2023

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 24 publications
(19 citation statements)
references
References 35 publications
1
18
0
Order By: Relevance
“…Our results are consistent with those reported by Kohen et al (2009), who demonstrated that cells grown on MatrigelBD retained all pluripotent stem cells features. Similar results reported by Chan et al (2011) demonstrated the biocompatibility of Puramatrix TM with DPSCs and SHEDs, showing that this hydrogel is compatible and allows cellular proliferation (Drury & Mooney; Chan et al). Here we revealed that MatrigelBD is easy to manipulate, it allows the inclusion of GMSCs, and it incorporates several growth factors that stimulate cellular proliferation, hence creating a suitable environment for the potential use in tissue reparation or regeneration.…”
Section: Discussionsupporting
confidence: 73%
“…Our results are consistent with those reported by Kohen et al (2009), who demonstrated that cells grown on MatrigelBD retained all pluripotent stem cells features. Similar results reported by Chan et al (2011) demonstrated the biocompatibility of Puramatrix TM with DPSCs and SHEDs, showing that this hydrogel is compatible and allows cellular proliferation (Drury & Mooney; Chan et al). Here we revealed that MatrigelBD is easy to manipulate, it allows the inclusion of GMSCs, and it incorporates several growth factors that stimulate cellular proliferation, hence creating a suitable environment for the potential use in tissue reparation or regeneration.…”
Section: Discussionsupporting
confidence: 73%
“…Some investigators reported the successful formation of lamellar bone in vivo by inducing human DPSCs to synthesize bone tissue in vitro and then transplanting it subcutaneously into mice, without needing of a scaffold support as the transplanted fibrous bone was an already formed hard tissue [ 48 , 49 ]. Chan et al used a self-assembling peptide hydrogel scaffold seeded with DPSC to create mineralised bone-like tissue pieces containing blood capillaries [ 50 ]. DPSCs with a mature osteogenic phenotype have been reported to be more responsive to pulsating fluid shear stress than osteogenically immature DPSCs and produce more bone in vivo suggesting that DPSCs with a mature osteogenic phenotype might be preferable for bone tissue engineering, because they might be able to perform mature bone cell-specific functions during bone adaptation to mechanical loading in vivo [ 51 ].…”
Section: Resultsmentioning
confidence: 99%
“…PLLA/differentiated hAFSC98 PLLA/n‐HA;99 PEOT/PBT/calcium phosphate/MSC;100 PCL/gelatin/n‐HA/differentiated DPSC;101 and Self‐assembling PA/differentiated DPSC102…”
Section: Medicinementioning
confidence: 99%
“…Thus, recently, stem cells have been usually incorporated into scaffolds to speed up tissue regeneration. The incorporation of MSCs,100, 103, 108, 110, 127, 128 amniotic fluid‐derived stem cells (AFSCs)98 and dental pulp stem cell (DPSCs),101, 102 etc. into nanofibous scaffolds helped to accelerate bone regeneration.…”
Section: Medicinementioning
confidence: 99%
See 1 more Smart Citation